AI MARKET SCANNING

Insmed Incorporated

AVG HISTORICAL GAP -2.41%
MAX GAP RECORD -14.72%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $INSM
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 06, 2026 Earnings Release 2026-08-06 (UNDETERMINED)
+0.00%
May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN)
-14.72%
Feb 19, 2026 Earnings Release 2026-02-19 (BEFORE OPEN)
+1.77%
Oct 30, 2025 Earnings Release 2025-10-30 (BEFORE OPEN)
+2.58%
Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN)
-4.23%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+0.00%
Feb 20, 2025 Earnings Release 2025-02-20 (BEFORE OPEN)
-4.45%
Oct 31, 2024 Earnings Release 2024-10-31 (BEFORE OPEN)
-2.43%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.2%
Bullish Gaps (2)
Bearish Gaps (9)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $INSM

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-20 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 309m +0.46%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗